[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:oropharyngeal-squamous-cell-carcinoma:hpv":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Oropharyngeal Squamous Cell Carcinoma","HPV",14,[8,16,22,28,34,41,47,53,59,66,72,78,84,90],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05268614","Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma",[12],"Phase 2","RECRUITING","2026-08-26T02:17:25.718160Z","2026-05-05T02:43:29.512737Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06223568","Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer",[12],"2026-08-03T03:13:22.003666Z","2026-05-05T02:43:29.471790Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT05419089","The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)",[12],"2026-08-26T02:17:04.346841Z","2026-05-05T02:43:28.852988Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT05541016","De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA",[12],"2026-08-26T02:16:13.426928Z","2026-05-05T02:43:28.485078Z",{"nct_id":35,"title":36,"phases":37,"status":13,"updated_at":39,"content_modified":40},"NCT06563479","A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer",[38],"Phase 3","2026-08-26T02:15:03.757872Z","2026-05-05T02:43:27.989005Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT07044635","Shortened Course of Radiation Therapy After Trans-oral Robotic Surgery in Patients With HPV-Mediated Oropharyngeal Squamous Cell Carcinoma.",[12],"2026-08-26T02:16:02.918558Z","2026-05-05T02:43:27.806024Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT05962242","HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma",[12],"2026-08-26T02:16:55.892527Z","2026-05-05T02:43:27.631667Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":57,"content_modified":58},"NCT04900623","Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study",[12],"2026-08-26T02:16:00.194860Z","2026-05-05T02:35:31.906438Z",{"nct_id":60,"title":61,"phases":62,"status":13,"updated_at":64,"content_modified":65},"NCT05639972","E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers",[63],"Phase 1\u002FPhase 2","2026-08-26T02:17:33.002248Z","2026-07-05T05:32:16.809101Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT06115772","Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP Study",[],"2026-08-26T02:19:19.975067Z","2026-05-13T02:55:06.420134Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT05600842","De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx",[],"2026-08-26T02:17:16.980188Z","2026-05-13T02:55:06.364729Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT06356272","Oropharynx (OPX) Biomarker Trial",[],"2026-08-26T02:15:10.362237Z","2026-05-13T02:55:06.483201Z",{"nct_id":85,"title":86,"phases":87,"status":13,"updated_at":88,"content_modified":89},"NCT06532279","Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer",[12],"2026-08-26T02:15:59.318403Z","2026-05-05T02:43:28.872744Z",{"nct_id":91,"title":92,"phases":93,"status":94,"updated_at":95,"content_modified":96},"NCT07513324","Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)",[12],"NOT_YET_RECRUITING","2026-08-26T02:19:07.104270Z","2026-05-05T02:43:28.871423Z"]